No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 2.2x · 10Y median 2.6x · 9th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 19
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T22:38:37.579Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T22:38:37.579Z. Latest historical point 2026-10-05.
EV/EBITDA and cash-flow multiples are withheld until their applicability to this financial-services business is verified. The lenses that apply are shown above; see also P/B and ROE.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T22:38:37.579Z. Latest historical point 2026-10-05.
EBITDA and cash-flow yields are withheld until their applicability to this financial-services business is verified. Earnings yield is shown above; see also P/B and ROE.
The latest delayed quote for Seven Hills Realty Trust (SEVN) stock was $6.90 as of Oct 6, 2026, 4:00 PM EDT, up 0.88% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -24.4% · 3-year avg -1.4%/yr · 5-year avg +2.5%/yr
Seven Hills Realty Trust functions as a real estate investment trust (REIT), concentrating on both the creation and acquisition of senior mortgage loans. These loans are specifically backed by middle-market and transitional commercial properties situated across the United States.
REIT - Mortgage · Newton, MA
Next Earnings Date
Oct 27, 2026
21 days away
EPS Estimate
0.24
Revenue Est.
$8.69M
Last Quarter Results
EPS
$0.23
vs Estimate
$0.25
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1SEVN | $131.55M | $6.90 | +0.88% | -24.43% | +2.55% | -2.07% | N/A |
| 2STHO | $106.38M | $8.80 | +0.34% | +7.31% | N/A | N/A | vs SEVN |
| 3SUNS | $80.30M | $5.94 | +0.00% | -31.51% | N/A | N/A | vs SEVN |
| 4MAYS | $80.07M | $39.72 | -0.95% | +5.50% | +1.08% | -1.36% | vs SEVN |
| 5CHCI | $188.23M | $18.75 | -2.19% | +34.52% | +32.25% | +25.68% | vs SEVN |
| 6ASPS | $68.98M | $6.04 | -3.97% | -50.92% | -39.86% | -31.17% | vs SEVN |
TTM
2.20
$8.13M
vs Estimate
$8.76M
Consensus Rating
Based on 5 analysts
Average Price Target
$9.55
+38.4% upside
Low
$8.50
Current
$6.90
High
$10.50
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.22 | $0.24 | $0.27 | 4 |
| Quarter ending Dec 2026 | $0.25 | $0.26 | $0.28 | 4 |
| Quarter ending Mar 2027 | $0.25 | $0.27 | $0.31 | 1 |
| Quarter ending Jun 2027 | $0.25 | $0.28 | $0.31 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $0.92 | $0.96 | $1.05 | 4 |
| FY 2027 | $1.02 | $1.12 | $1.20 | 4 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $8.07M | $8.69M | $9.83M | 3 |
| Quarter ending Dec 2026 | $8.55M | $9.20M | $10.05M | 3 |
| Quarter ending Mar 2027 | $8.84M | $9.50M | $10.38M | 1 |
| Quarter ending Jun 2027 | $9.09M | $9.78M | $10.68M | 1 |
Annual
| Period | Low |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Dec 31, 2026, matching Key Metrics.
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $33.18M | $34.32M | $36.28M | 3 |
| FY 2027 | $38.61M | $39.37M | $40.35M | 3 |
